Cargando…

Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate

INTRODUCTION: We identified silent liver fibrosis in patients with rheumatoid arthritis (RA) using transient elastography, and investigated medication that correlated with abnormal liver stiffness measurement (LSM) values. METHODS: We consecutively enrolled 105 patients with RA taking methotrexate o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sang-Won, Park, Hee-Jin, Kim, Beom Kyung, Han, Kwang-Hyub, Lee, Soo-Kon, Kim, Seung Up, Park, Yong-Beom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580544/ https://www.ncbi.nlm.nih.gov/pubmed/23107811 http://dx.doi.org/10.1186/ar4075

Ejemplares similares

Evaluation of efficacy of combination of methotrexate and hydroxychloroquine with leflunomide in active rheumatoid arthritis
por: Shashikumar, N.S., et al.
Publicado: (2010)

Comparative Effectiveness of Tocilizumab with either Methotrexate or Leflunomide in the Treatment of Rheumatoid Arthritis
por: Narváez, Javier, et al.
Publicado: (2015)

Combination of Methotrexate and Leflunomide Is Efficient and Safe for 60 Patients with Rheumatoid Arthritis
por: Chen, Fang, et al.
Publicado: (2022)

Methotrexate-loaded multifunctional nanoparticles with near-infrared irradiation for the treatment of rheumatoid arthritis
por: Ha, You-Jung, et al.
Publicado: (2020)

The Effect of Leflunomide on Cold and Vibratory Sensation in Patients with Rheumatoid Arthritis
por: Kim, Hyung Kuk, et al.
Publicado: (2012)

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
por: Chang, Jin Won, et al.
Publicado: (2021)

IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide
por: Zhong, Wei, et al.
Publicado: (2017)

Efficacy and safety of total glucosides of paeony combined with methotrexate and leflunomide for active rheumatoid arthritis: a meta-analysis
por: Huang, Yao, et al.
Publicado: (2019)

Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
por: Jones, Peter BB, et al.
Publicado: (2010)

Clinical efficacy and safety of methotrexate compared with leflunomide in the treatment of rheumatoid arthritis: A protocol for systematic review and meta-analysis
por: Qi, Weiyu, et al.
Publicado: (2021)

PReS-FINAL-2048: Treatment with methotrexate plus leflunomide for juvenile idiopathic arthritis
por: Quesada-Masachs, E, et al.
Publicado: (2013)

Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
por: Heo, Ja Yoon, et al.
Publicado: (2018)

Inflammatory Polyarthritis in a Patient with Psoriasis: Is It Psoriatic Arthritis or Rheumatoid Arthrirtis?
por: Lee, Kwang-Hoon, et al.
Publicado: (2010)

Discordance between Liver Biopsy and FibroScan® in Assessing Liver Fibrosis in Chronic Hepatitis B: Risk Factors and Influence of Necroinflammation
por: Kim, Seung Up, et al.
Publicado: (2012)

Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy
por: Lee, Hye Won, et al.
Publicado: (2019)

Traditional Chinese medicine Biqi capsule compared with leflunomide in combination with methotrexate in patients with rheumatoid arthritis: a randomized controlled trial
por: Wang, Zhang, et al.
Publicado: (2020)

Leflunomide-induced and paraneoplastic ulcers in a rheumatoid arthritis patient
por: Vittori, Michael R., et al.
Publicado: (2022)

Prospective Validation of ELF Test in Comparison with Fibroscan and FibroTest to Predict Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
por: Kim, Beom Kyung, et al.
Publicado: (2012)

Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
por: Lee, Sangheun, et al.
Publicado: (2015)

Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
por: Sung, Min Je, et al.
Publicado: (2020)

Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis
por: Kang, Yoon, et al.
Publicado: (2013)

Discordance between Liver Biopsy and FibroTest in Assessing Liver Fibrosis in Chronic Hepatitis B
por: Park, Mi Sung, et al.
Publicado: (2013)

Differential effects of leflunomide and methotrexate on cytokine production in RA
por: Kraan, MC, et al.
Publicado: (2003)

The Correlation between Increased Serum Concentrations of Interleukin-6 Family Cytokines and Disease Activity in Rheumatoid Arthritis Patients
por: Chung, Soo-Jin, et al.
Publicado: (2011)

Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients
por: Hopkins, AM, et al.
Publicado: (2015)

Interleukin-18 in Brazilian Rheumatoid Arthritis Patients: Can Leflunomide Reduce It?
por: Gualberto Cardoso, Pablo Ramon, et al.
Publicado: (2021)

Silent Microbleeds and Hemorrhagic Conversion of an Embolic Infarction
por: Kim, Beom Joon, et al.
Publicado: (2007)

Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort
por: Fautrel, Bruno, et al.
Publicado: (2012)

The -174G/C Interleukin-6 Gene Promoter Polymorphism as a Genetic Marker of Differences in Therapeutic Response to Methotrexate and Leflunomide in Rheumatoid Arthritis
por: Ruiz-Padilla, A. J., et al.
Publicado: (2016)

Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab
por: Burmester, Gerd R, et al.
Publicado: (2017)

Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis
por: Kang, Young Mo, et al.
Publicado: (2018)

Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
por: Lee, Hye Won, et al.
Publicado: (2018)

Primary idiopathic silent chylopericardium
por: Kwon, Jong Bum, et al.
Publicado: (2013)

Combination leflunomide and methotrexate impedes the recovery of liver fibrosis, partly through inhibition of myeloid cell admittance
por: Lin, Mengxin, et al.
Publicado: (2019)

A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
por: Lee, Jae Seung, et al.
Publicado: (2020)

Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
por: Kim, Beom Kyung, et al.
Publicado: (2012)

Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
por: Kim, Seung Up, et al.
Publicado: (2016)

Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
por: Lee, Hye Won, et al.
Publicado: (2019)

Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals
por: Lee, Hye Won, et al.
Publicado: (2019)

Author Correction: Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
por: Lee, Hye Won, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_66emk239j9rtnmic49jllo3bkm